Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats

J Kassa, J Karasova, L Vasina, J Bajgar, K Kuca, K Musilek

Jazyk angličtina Země Velká Británie

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12008553
E-zdroje

NLK Medline Complete (EBSCOhost) od 2000-02-01 do Před 1 rokem

The neuroprotective effects of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in combination with atropine in rats poisoned with tabun at a sublethal dose (180 microg/kg i.m.; 80% LD(50)) were studied. The tabun-induced neurotoxicity was monitored by using a functional observational battery and an automatic measurement of motor activity. The neurotoxicity of tabun was monitored at 24 hours and 7 days following tabun challenge. The results indicate that K203 and obidoxime in combination with atropine allow all tabun-poisoned rats to survive within 7 days following tabun challenge, while 2 nontreated tabun-poisoned rats and 1 tabun-poisoned rat treated with K206 or HI-6 in combination with atropine died within 7 days. Only one of the newly developed oximes (K203) combined with atropine seems to be effective for a decrease in tabun-induced neurotoxicity within 24 hours after tabun sublethal poisoning, although it is not able to eliminate tabun-induced neurotoxicity completely. On the other hand, the neuroprotective efficacy of commonly used oximes (obidoxime and HI-6), as well as one of the new synthesized oximes (K206), is significantly lower in comparison with K203, according to the number of eliminated tabun-induced neurotoxic signs at 24 hours after tabun challenge. Due to its neuroprotective effects, K203 appears to be a suitable oxime for the antidotal treatment of acute tabun poisonings.

000      
03357naa a2200469 a 4500
001      
bmc12008553
003      
CZ-PrNML
005      
20250521160952.0
008      
120316s2009 xxk eng||
009      
AR
040    __
$a ABA008 $b cze $d ABA008
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kassa, Jiří, $d 1956- $7 mzk2003181395 $u Department of Toxicology, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic. kassa@pmfhk.cz
245    12
$a A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats / $c J Kassa, J Karasova, L Vasina, J Bajgar, K Kuca, K Musilek
520    9_
$a The neuroprotective effects of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in combination with atropine in rats poisoned with tabun at a sublethal dose (180 microg/kg i.m.; 80% LD(50)) were studied. The tabun-induced neurotoxicity was monitored by using a functional observational battery and an automatic measurement of motor activity. The neurotoxicity of tabun was monitored at 24 hours and 7 days following tabun challenge. The results indicate that K203 and obidoxime in combination with atropine allow all tabun-poisoned rats to survive within 7 days following tabun challenge, while 2 nontreated tabun-poisoned rats and 1 tabun-poisoned rat treated with K206 or HI-6 in combination with atropine died within 7 days. Only one of the newly developed oximes (K203) combined with atropine seems to be effective for a decrease in tabun-induced neurotoxicity within 24 hours after tabun sublethal poisoning, although it is not able to eliminate tabun-induced neurotoxicity completely. On the other hand, the neuroprotective efficacy of commonly used oximes (obidoxime and HI-6), as well as one of the new synthesized oximes (K206), is significantly lower in comparison with K203, according to the number of eliminated tabun-induced neurotoxic signs at 24 hours after tabun challenge. Due to its neuroprotective effects, K203 appears to be a suitable oxime for the antidotal treatment of acute tabun poisonings.
590    __
$a bohemika - dle Pubmed
650    02
$a zvířata $7 D000818
650    02
$a chemické bojové látky $x škodlivé účinky $7 D002619
650    02
$a cholinesterasové inhibitory $x škodlivé účinky $7 D002800
650    02
$a reaktivátory cholinesterasy $x terapeutické užití $7 D002801
650    02
$a modely nemocí na zvířatech $7 D004195
650    02
$a mužské pohlaví $7 D008297
650    02
$a neuroprotektivní látky $x škodlivé účinky $x terapeutické užití $7 D018696
650    02
$a neurotoxické syndromy $x enzymologie $x etiologie $x prevence a kontrola $7 D020258
650    02
$a obidoxim chlorid $x terapeutické užití $7 D009768
650    02
$a organofosforové sloučeniny $x škodlivé účinky $7 D009943
650    02
$a oximy $x terapeutické užití $7 D010091
650    02
$a organofosfáty $x škodlivé účinky $7 D010755
650    02
$a krysa rodu Rattus $7 D051381
650    02
$a potkani Wistar $7 D017208
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Žďárová Karasová, Jana, $d 1982- $7 xx0099787
700    1_
$a Vašina, Libor $7 xx0332175
700    1_
$a Bajgar, Jiří, $d 1944- $7 js20020122033
700    1_
$a Kuča, Kamil, $d 1978- $7 xx0041831
700    1_
$a Musílek, Kamil, $d 1980- $7 xx0135628
773    0_
$t Drug and chemical toxicology $p Drug Chem Toxicol $g Roč. 32, č. 2 (2009), s. 128-138 $w MED00001436 $x 0143-2044
773    0_
$p Drug Chem Toxicol $g 32(2):128-38, 2009
910    __
$a ABA008 $b x $y 4 $z 0
990    __
$a 20120319124515 $b ABA008
991    __
$a 20250521160950 $b ABA008
999    __
$a ok $b bmc $g 901919 $s 765448
BAS    __
$a 3
BMC    __
$a 2009 $b 32 $c 2 $d 128-138 $m Drug and chemical toxicology $x MED00001436
LZP    __
$a 2012-1Q10/jj

Najít záznam